This topic contains a solution. Click here to go to the answer

Author Question: Which of the following statements is true concerning the treatment of fibromyalgia syndrome? a. ... (Read 58 times)

Tazate

  • Hero Member
  • *****
  • Posts: 532
Which of the following statements is true concerning the treatment of fibromyalgia syndrome?
 
  a. There is currently no cure for the disorder; however, patients should be made aware that symptom relief is possible.
  b. Treatment is directed toward controlling discomfort, improving sleep, and maintaining function.
  c. Fibromyalgia syndrome can be difficult to manage, requiring a variety of approaches and multiple medications.
  d. All of the above

Question 2

Mrs. Allen is a 60-year-old woman who has been diagnosed with osteoporosis. She is very concerned about the risk of breast cancer associated with hormone replacement therapy and is wondering what else is available to her.
 
  The clinician explains that biphosphonates are another class of drugs used in the prevention and treatment of osteoporosis. What teaching should the clinician give Mrs. Allen in regard to taking biphosphonates?
 
  a. Taking biphosphonates can result in hypercalcemia, so calcium intake should be decreased while taking this class of drugs.
  b. There is potential for upper gastrointestinal (GI) irritation, so these medications are contraindicated in people with abnormalities of the esophagus or delayed esophageal emptying.
  c. This class of drugs can be taken at any time of the day without regard to meals.
  d. None of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Tonyam972

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

ANS: D

Answer to Question 2

ANS: B




Tazate

  • Member
  • Posts: 532
Reply 2 on: Jul 22, 2018
Wow, this really help


Liddy

  • Member
  • Posts: 342
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

There are more nerve cells in one human brain than there are stars in the Milky Way.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Cucumber slices relieve headaches by tightening blood vessels, reducing blood flow to the area, and relieving pressure.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

For a complete list of videos, visit our video library